The Journal of Clinical Endocrinology & Metabolism · 2012 · 56 citations · 15 references
MedicineBiochemistryEndocrinologyDementiaInflammationPathophysiologyAlzheimer DiseaseDiabetes MellitusInsulin ResistanceNeuroinflammationWeight LossWeight ManagementAlzheimer Disease ProgressionAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid FibrillogenesisAmyloid PlaquesBariatric Surgery Weight LossInsulin Resistance AssessmentObesity-associated Insulin Resistance
OBJECTIVE: Obesity and type 2 diabetes are associated with an increase in the incidence and prevalence of Alzheimer's disease (AD) and an impaired cognitive function. Because peripheral blood mononuclear cells (MNC) express amyloid precursor protein (APP), the precursor of β-amyloid, which forms the pathognomonic plaques in the brain, we hypothesized that APP expression diminishes after the marked caloric restriction and weight loss associated with Roux-en-Y gastric bypass (RYGB) surgery. RESEARCH DESIGN AND METHODS: Fifteen type 2 diabetic patients with morbid obesity (body mass index, 52.1 ± 13 kg/m(2)) underwent RYGB, and the expression of inflammatory and AD-related genes was examined before and after 6 months in plasma and in MNC. RESULTS: Body mass index fell to 40.4 ± 11.1 kg/m(2) at 6 months after RYGB. There was a significant fall in plasma concentrations of glucose and insulin and in homeostasis model of assessment for insulin resistance. The expression of APP mRNA fell by 31 ± 9%, and that of protein fell by 36 ± 14%. In addition, there was a reduction in the expression of other AD-related genes including presinilin-2, ADAM-9, GSK-3β, PICALM, SORL-1, and clusterin (P < 0.05 for all). Additionally, the expression of c-Fos, a subunit of the proinflammatory transcription factor AP-1, was also suppressed after RYGB. These changes occurred in parallel with reductions in other proinflammatory mediators including C-reactive protein and monocyte chemoattractant protein-1. CONCLUSIONS: Thus, the reversal of the proinflammatory state of obesity is associated with a concomitant reduction in the expression of APP and other AD-related genes in MNC. We conclude that obesity and caloric intake modulate the expression of APP in MNC. If indeed, this effect also occurs in the brain, this may have implications for the pathogenesis and the treatment of AD. It is relevant that cognitive function has been shown to improve with weight loss following bariatric surgery.
15
Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function
Zoe Arvanitakis, R. J. Wilson, Julia L. Bienias et al. · Archives of Neurology · 2004 · 1.3K citations
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Ekaterina Rogaeva, Yan Meng, Joseph H. Lee et al. · Nature Genetics · 2007 · 1.2K citations · Full text
Husam Ghanim, Sanaa Abuaysheh, C.L. Sia et al. · Diabetes Care · 2009 · 488 citations · Full text
Paresh Dandona, Priya Mohanty, Husam Ghanim et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 372 citations · Full text